
MRNA Stock Up 2%, Moderna Signs Deal to Ramp Up 1B COVID-19 Vaccine Doses a Year
Moderna is moving forward with its coronavirus vaccine. The company announced a deal with Lonza Group AG to manufacture 1 billion coronavirus vaccine doses a year. MRNA stock is up.